This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Amlodipine and olmesartan medoxomil

Read time: 1 mins
Marketing start date: 22 Dec 2024
...
 

Summary of product characteristics


Effective Time

20221013

Version

4

Spl Product Data Elements

Amlodipine and olmesartan medoxomil Amlodipine and olmesartan medoxomil AMLODIPINE BESYLATE AMLODIPINE OLMESARTAN MEDOXOMIL OLMESARTAN ANHYDROUS LACTOSE CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE STARCH, CORN TALC TITANIUM DIOXIDE WHITE ROUND 927 Amlodipine and olmesartan medoxomil Amlodipine and olmesartan medoxomil AMLODIPINE BESYLATE AMLODIPINE OLMESARTAN MEDOXOMIL OLMESARTAN ANHYDROUS LACTOSE CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM FERRIC OXIDE RED FERRIC OXIDE YELLOW HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE STARCH, CORN TALC TITANIUM DIOXIDE ORANGE ROUND 928 Amlodipine and olmesartan medoxomil Amlodipine and olmesartan medoxomil AMLODIPINE BESYLATE AMLODIPINE OLMESARTAN MEDOXOMIL OLMESARTAN ANHYDROUS LACTOSE CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM FERRIC OXIDE RED FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE STARCH, CORN TALC TITANIUM DIOXIDE PALE YELLOW ROUND 929 Amlodipine and olmesartan medoxomil Amlodipine and olmesartan medoxomil AMLODIPINE BESYLATE AMLODIPINE OLMESARTAN MEDOXOMIL OLMESARTAN ANHYDROUS LACTOSE CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM FERRIC OXIDE RED FERRIC OXIDE YELLOW HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE STARCH, CORN TALC TITANIUM DIOXIDE ORANGE ROUND 930

Application Number

ANDA207771

Brand Name

Amlodipine and olmesartan medoxomil

Generic Name

Amlodipine and olmesartan medoxomil

Product Ndc

70771-1187

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1186-3 Amlodipine and olmesartan medoxomil tablets, 5/20 mg Rx only 30 tablets NDC 70771-1187-3 Amlodipine and olmesartan medoxomil tablets, 10/20 mg Rx only 30 tablets NDC 70771-1188-3 Amlodipine and olmesartan medoxomil tablets, 5/40 mg Rx only 30 tablets NDC 70771-1189-3 Amlodipine and olmesartan medoxomil tablets, 10/40 mg Rx only 30 tablets Amlodipine and olmesartan medoxomil tablets Amlodipine and olmesartan medoxomil tablets Amlodipine and olmesartan medoxomil tablets Amlodipine and olmesartan medoxomil tablets

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.